These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 18204862)
1. Upregulation of topoisomerase IIalpha expression in advanced gallbladder carcinoma: a potential chemotherapeutic target. Washiro M; Ohtsuka M; Kimura F; Shimizu H; Yoshidome H; Sugimoto T; Seki N; Miyazaki M J Cancer Res Clin Oncol; 2008 Jul; 134(7):793-801. PubMed ID: 18204862 [TBL] [Abstract][Full Text] [Related]
2. Altered expression of topoisomerase IIalpha contributes to cross-resistant to etoposide K562/MX2 cell line by aberrant methylation. Asano T; Nakamura K; Fujii H; Horichi N; Ohmori T; Hasegawa K; Isoe T; Adachi M; Otake N; Fukunaga Y Br J Cancer; 2005 Apr; 92(8):1486-92. PubMed ID: 15798770 [TBL] [Abstract][Full Text] [Related]
3. Modulation of topoisomerase IIalpha expression by a DNA sequence-specific polyamide. Hochhauser D; Kotecha M; O'hare C; Morris PJ; Hartley JM; Taherbhai Z; Harris D; Forni C; Mantovani R; Lee M; Hartley JA Mol Cancer Ther; 2007 Jan; 6(1):346-54. PubMed ID: 17237293 [TBL] [Abstract][Full Text] [Related]
4. Modulation of topoisomerase IIα expression and chemosensitivity through targeted inhibition of NF-Y:DNA binding by a diamino p-anisyl-benzimidazole (Hx) polyamide. Pett L; Kiakos K; Satam V; Patil P; Laughlin-Toth S; Gregory M; Bowerman M; Olson K; Savagian M; Lee M; Lee M; Wilson WD; Hochhauser D; Hartley JA Biochim Biophys Acta Gene Regul Mech; 2017 May; 1860(5):617-629. PubMed ID: 27750031 [TBL] [Abstract][Full Text] [Related]
5. Treatment with gefitinib or lapatinib induces drug resistance through downregulation of topoisomerase IIα expression. Bhosle J; Kiakos K; Porter AC; Wu J; Makris A; Hartley JA; Hochhauser D Mol Cancer Ther; 2013 Dec; 12(12):2897-908. PubMed ID: 24092808 [TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of DNA topoisomerase II genes in human medulloblastoma and its possible association with etoposide sensitivity. Uesaka T; Shono T; Kuga D; Suzuki SO; Niiro H; Miyamoto K; Matsumoto K; Mizoguchi M; Ohta M; Iwaki T; Sasaki T J Neurooncol; 2007 Sep; 84(2):119-29. PubMed ID: 17361331 [TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of topoisomerase II alpha and evaluation of its effects on cell proliferation and apoptosis in glioblastoma cancer stem cells. Hong Y; Sang M; Shang C; Xue YX; Liu YH Neurosci Lett; 2012 Jun; 518(2):138-43. PubMed ID: 22569122 [TBL] [Abstract][Full Text] [Related]
8. Decreased topoisomerase IIα expression and altered histone and regulatory factors of topoisomerase IIα promoter in patients with chronic benzene poisoning. Yu K; Shi YF; Yang KY; Zhuang Y; Zhu RH; Xu X; Cai G Toxicol Lett; 2011 Jun; 203(2):111-7. PubMed ID: 21382456 [TBL] [Abstract][Full Text] [Related]
9. DNA topoisomerase II-alpha as a proliferation marker in human gliomas: correlation with PCNA expression and patient survival. Zhao H; Yu H; Liu Y; Wang Y; Cai W Clin Neuropathol; 2008; 27(2):83-90. PubMed ID: 18402387 [TBL] [Abstract][Full Text] [Related]
10. Expression of drug resistance genes in VP-16 and mAMSA-selected human carcinoma cells. Matsumoto Y; Takano H; Kunishio K; Nagao S; Fojo T Jpn J Cancer Res; 2001 Jul; 92(7):778-84. PubMed ID: 11473729 [TBL] [Abstract][Full Text] [Related]
11. β-Elemene Inhibits Cell Proliferation by Regulating the Expression and Activity of Topoisomerases I and IIα in Human Hepatocarcinoma HepG-2 Cells. Gong M; Liu Y; Zhang J; Gao YJ; Zhai PP; Su X; Li X; Li Y; Hou L; Cui XN Biomed Res Int; 2015; 2015():153987. PubMed ID: 26221582 [TBL] [Abstract][Full Text] [Related]
12. UPR-induced resistance to etoposide is downstream of PERK and independent of changes in topoisomerase IIα levels. Mann MJ; Pereira ER; Liao N; Hendershot LM PLoS One; 2012; 7(10):e47931. PubMed ID: 23144714 [TBL] [Abstract][Full Text] [Related]
13. Topoisomerase IIalpha mRNA and protein expression in ovarian carcinoma: correlation with clinicopathological factors and prognosis. Faggad A; Darb-Esfahani S; Wirtz R; Sinn B; Sehouli J; Könsgen D; Lage H; Weichert W; Noske A; Budczies J; Müller BM; Buckendahl AC; Röske A; Eldin Elwali N; Dietel M; Denkert C Mod Pathol; 2009 Apr; 22(4):579-88. PubMed ID: 19270648 [TBL] [Abstract][Full Text] [Related]
14. The mechanisms of somatostatin induced enhanced chemosensitivity of gallbladder cancer cell line to doxorubicin: cell cycle modulation plus target enzyme up-regulation. Quan ZW; Yang Y; Li JY; Gong W; Qin YY; Li SG Biomed Pharmacother; 2010 Sep; 64(7):451-7. PubMed ID: 20359855 [TBL] [Abstract][Full Text] [Related]
15. DNA topoisomerase IIalpha and -beta expression in human ovarian cancer. Withoff S; van der Zee AG; de Jong S; Hollema H; Smit EF; Mulder NH; de Vries EG Br J Cancer; 1999 Feb; 79(5-6):748-53. PubMed ID: 10070864 [TBL] [Abstract][Full Text] [Related]
16. Gambogic acid inhibits the catalytic activity of human topoisomerase IIalpha by binding to its ATPase domain. Qin Y; Meng L; Hu C; Duan W; Zuo Z; Lin L; Zhang X; Ding J Mol Cancer Ther; 2007 Sep; 6(9):2429-40. PubMed ID: 17876042 [TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human breast cancer cells. Zhou Z; Zwelling LA; Kawakami Y; An T; Kobayashi K; Herzog C; Kleinerman ES Cancer Res; 1999 Sep; 59(18):4618-24. PubMed ID: 10493516 [TBL] [Abstract][Full Text] [Related]
18. Induction of sensitivity to doxorubicin and etoposide by transfection of MCF-7 breast cancer cells with heregulin beta-2. Harris LN; Yang L; Tang C; Yang D; Lupu R Clin Cancer Res; 1998 Apr; 4(4):1005-12. PubMed ID: 9563896 [TBL] [Abstract][Full Text] [Related]
19. HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase IIalpha. Stros M; Polanská E; Struncová S; Pospísilová S Nucleic Acids Res; 2009 Apr; 37(7):2070-86. PubMed ID: 19223331 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of topoisomerase IIalpha expression by transforming growth factor-beta1 is abrogated by the papillomavirus E7 protein. Satterwhite DJ; White RL; Matsunami N; Neufeld KL Cancer Res; 2000 Dec; 60(24):6989-94. PubMed ID: 11156401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]